01 / Biopharma
Biopharma
Regulatory, clinical, and CMC teams
Rewrite risk becomes a reviewable change set.
A program team keeps the dossier aligned as the science changes.
Raycaster reads protocols, CSRs, Module 2 and 3 sections, SOPs, spreadsheets, and guidance as connected source material. When a study endpoint, assay limit, or process parameter changes, the team can see which documents need attention before submission pressure builds.
Pressure
Small scientific changes travel far. A single update can touch tables, justifications, summaries, methods, and regional commitments.
Raycaster workflow
- Map the program files, guidance, source tables, and prior submission language.
- Ask Raycaster to find every affected section and explain why it matters.
- Stage tracked changes for medical writers, CMC leads, and regulatory owners to review.
Business value
- The team reviews a cited change list instead of checking every file by hand.
- Writers spend more time on scientific judgment and less time reconciling versions.
- Each accepted edit keeps a path back to the source evidence.